DBMYX
Price
$27.24
Change
-$0.13 (-0.47%)
Updated
Sep 20 closing price
PAMCX
Price
$103.39
Change
-$0.73 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

DBMYX vs PAMCX

Header iconDBMYX vs PAMCX Comparison
Open Charts DBMYX vs PAMCXBanner chart's image
BNY Mellon Sm/Md Cp Gr Y
Price$27.24
Change-$0.13 (-0.47%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth Adv
Price$103.39
Change-$0.73 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
DBMYX vs PAMCX Comparison Chart
Loading...
VS
DBMYX vs. PAMCX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBMYX is a Buy and PAMCX is a StrongBuy.

FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 31.4B vs. DBMYX (1.29B). DBMYX (0.00) and PAMCX (0.00) have matching dividends . DBMYX was incepted earlier than PAMCX: DBMYX (11 years) vs PAMCX (24 years). DBMYX is a more actively managed with annual turnover of: 36.02 vs. PAMCX (21.70). PAMCX has a lower initial minimum investment than DBMYX: PAMCX (2500) vs DBMYX (1000000). DBMYX annual gain was more profitable for investors over the last year : 17.11 vs. PAMCX (14.18). DBMYX return over 5 years is better than : 19.26 vs. PAMCX (12.05).
DBMYXPAMCXDBMYX / PAMCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years24 years-
Gain YTD2.2918.82026%
Front LoadN/AN/A-
Min. Initial Investment1000000250040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.29B31.4B4%
Annual Yield % from dividends0.000.00-
Returns for 1 year17.1114.18121%
Returns for 3 years-32.62-14.88219%
Returns for 5 years19.2612.05160%
Returns for 10 years49.8338.63129%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMMT24.391.23
+5.31%
Summit Therapeutics
TENX3.62N/A
N/A
Tenax Therapeutics
NWE56.47-0.38
-0.67%
NorthWestern Energy Group
HBIO2.75-0.03
-1.08%
Harvard Bioscience
CDMO11.60-0.85
-6.83%
Avid Bioservices